Decentralised Trials (DCT) – Direct to patient benefits

Direct to patient shipment functionality provides the ability for a site to register a visit with home delivery of investigational material. This type of protocol design can help with:

• Patient retention by lessening the burden of traveling to every dispensing site visit

• Prevention of wasted investigational material at sites with low or no enrollment

• Agility for a changing supply chain landscape